Phase 1 Study of rHSA/GCSF in Neutropenia After Chemotherapy of Cancer Patients
Phase 1 Study of rHSA/GCSF in Neutropenia After Chemotherapy of Cancer Patients
Safety and efficacy studies of rHSA/GCSF fusion protein for injection in treatment of neutropenia induced by chemotherapy of cancer patients.
A dosage climbing for the safety and efficacy studies for the neutropenia induced by chemotherapy cancer patients Repeat-dose studies for the safety and efficacy studied for the neutropenia.
Inclusion Criteria:
- chemotherapy induced neutropenia
Exclusion Criteria:
- treated with other biological drugs or other neutropenia therapy drugs